POC Breast 1 | 2007 - Adjuvant Trastuzumab
Breast Adjuvant Chemotherapy
HER-2/neu:Predictive Marker for Response to Breast Cancer Therapy Mark Pegram, M.D. Associate Professor of Medicine Director, Women’s Cancer Program UCLA/Jonsson.
Supplemental Figures Loss of circadian clock gene expression is associated with tumor progression in breast cancer Cristina Cadenas 1*, Leonie van de Sandt.
Adjuvant Therapy For Breast Cancer. Breast Cancer | Epidemiology- Australia Australian Institute of Health and Welfare 2014. ACIM (Australian Cancer Incidence.
TAP Vol 1 Issue 4
